Valproic Acid and Lamotrigine Differentially Modulate the Telomere Length in Epilepsy Patients
Open Access
- 3 January 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 255
Abstract
Background/Objectives: Antiseizure drugs (ASDs) are the primary therapy for epilepsy, and the choice varies according to seizure type. Epilepsy patients experience chronic mitochondrial oxidative stress and increased levels of pro-inflammatory mediators, recognizable hallmarks of biological aging; however, few studies have explored aging markers in epilepsy. Herein, we addressed for the first time the impact of ASDs on molecular aging by measuring the telomere length (TL) and mtDNA copy number (mtDNA-CN). Methods: We used real-time quantitative PCR (QPCR) in epilepsy patients compared to matched healthy controls (CTs) and assessed the association with plasma levels of ASDs and other clinical variables. The sample comprised 64 epilepsy patients and 64 CTs. Patients were grouped based on monotherapy with lamotrigine (LTG) or valproic acid (VPA), and those treated with a combination therapy (LTG + VPA). Multivariable logistic regression was applied to analyze the obtained data. Results: mtDNA-CN was similar between patients and controls, and none of the comparisons were significant for this marker. TL was shorter in not seizure-free patients than in CTs (1.50 ± 0.35 vs. 1.68 ± 0.34; p < 0.05), regardless of the ASD therapy. These patients exhibited the highest proportion of adverse drug reactions. TL was longer in patients on VPA monotherapy, followed by patients on LTG monotherapy and patients on an LTG + VPA combined scheme (1.77 ± 0.24; 1.50 ± 0.32; 1.36 ± 0.37, respectively; p < 0.05), suggesting that ASD treatment differentially modulates TL. Conclusions: Our findings suggest that clinicians could consider TL measurements to decide the best ASD treatment option (VPA and/or LTG) to help predict ASD responses in epilepsy patients.Keywords
All Related Versions
Funding Information
- Universidad Autónoma Metropolitana Unidad Xochimilco (34605034)
This publication has 65 references indexed in Scilit:
- Neuropharmacology of Antiseizure DrugsNeuropsychopharmacology Reports, 2021
- Leukocyte mitochondrial DNA copy number in schizophreniaAsian Journal of Psychiatry, 2020
- Nuevos fármacos antiepilépticos en PediatríaAnales de Pediatría, 2019
- Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunctionBiogerontology, 2018
- Mitochondria, its DNA and telomeres in ageing and human populationBiogerontology, 2018
- Telomerase activation as a possible mechanism of action for psychopharmacological interventionsDrug Discovery Today, 2015
- Telomere length and common disease: study design and analytical challengesHuman Genetics, 2015
- Lamotrigine extends lifespan but compromises health span in Drosophila melanogasterBiogerontology, 2009
- Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat BrainNeurochemical Research, 2007
- Chronic Treatment with Mood Stabilizers Lithium and Valproate Prevents Excitotoxicity by Inhibiting Oxidative Stress in Rat Cerebral Cortical CellsBiological Psychiatry, 2005